Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
178
-
Total 13F shares, excl. options
-
27.3M
-
Shares change
-
-552K
-
Total reported value, excl. options
-
$1.24B
-
Value change
-
-$14.3M
-
Put/Call ratio
-
0.35
-
Number of buys
-
79
-
Number of sells
-
-76
-
Price
-
$45.36
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q4 2020
206 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.3M shares
of 51.1M outstanding shares and own 53.3% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.43M shares), VANGUARD GROUP INC (3.34M shares), JPMORGAN CHASE & CO (2.6M shares), Redmile Group, LLC (2.12M shares), STATE STREET CORP (1.82M shares), GOLDMAN SACHS GROUP INC (730K shares), DIMENSIONAL FUND ADVISORS LP (691K shares), GEODE CAPITAL MANAGEMENT, LLC (523K shares), Aquilo Capital Management, LLC (503K shares), and Korea Investment CORP (490K shares).
This table shows the top 178 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.